Reactivation of mutant-EGFR degradation through clathrin inhibition overcomes resistance to EGFR tyrosine kinase inhibitors

Ludovic Ménard*, Nicolas Floc'h, Matthew J. Martin, Darren A.E. Cross

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

19 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Reactivation of mutant-EGFR degradation through clathrin inhibition overcomes resistance to EGFR tyrosine kinase inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences